Professional Documents
Culture Documents
Over the last two decades, the incidence of obesity and asso- brates. New data identify tributyltin chloride and triphenyl-
ciated metabolic syndrome diseases has risen dramatically, tin chloride as nanomolar agonist ligands for retinoid X
becoming a global health crisis. Increased caloric intake and receptor (RXR␣, RXR, and RXR␥) and peroxisome prolifera-
decreased physical activity are believed to represent the root tor-activated receptor ␥, nuclear receptors that play pivotal
causes of this dramatic rise. However, recent findings high- roles in lipid homeostasis and adipogenesis. The environmen-
light the possible involvement of environmental obesogens, tal obesogen hypothesis predicts that inappropriate receptor
xenobiotic chemicals that can disrupt the normal develop- activation by organotins will lead directly to adipocyte dif-
mental and homeostatic controls over adipogenesis and en- ferentiation and a predisposition to obesity and/or will sen-
ergy balance. Environmental estrogens, i.e. chemicals with sitize exposed individuals to obesity and related metabolic
estrogenic potential, have been reported to perturb adipo- disorders under the influence of the typical high-calorie, high-
genic mechanisms using in vitro model systems, but other fat Western diet. The linking of organotin exposure to adipo-
classes of endocrine-disrupting chemicals are now coming cyte differentiation and obesity opens an important new area
under scrutiny as well. Organotins represent one class of of research into potential environmental influences on human
widespread persistent organic pollutants with potent endo- health and disease. (Endocrinology 147: S50 –S55, 2006)
crine-disrupting properties in both invertebrates and verte-
S50
Grün and Blumberg • Are Environmental Chemicals Making Us Fat? Endocrinology, June 2006, 147(6) (Supplement):S50 –S55 S51
molecular targets, and potential cellular mechanisms uses. Human exposure to non-point sources of organotins
through which they might act. occurs through contaminated dietary sources (seafood and
Although until now data have been scant, some epidemi- shellfish), as fungicides on food crops, and as antifungal
ological and in vitro studies suggested a link between envi- agents in wood treatments, industrial water systems, and
ronmental chemical exposure and obesity. These serve as textiles (30). A variety of mono- and dialkyltins, which in-
proof-of-principle for a chemical obesogen hypothesis. For clude significant contaminating trialkyl species, are also
instance, the risk of childhood obesity is associated with prevalently used as heat stabilizers in the manufacture of
maternal smoking during pregnancy. Smoking before or polyolefin (PVC) plastics, bringing them into closer contact
during pregnancy, but not afterward, increased the odds with drinking water and food supplies. Measured exposure
(49), to test a high-priority list of known or suspected envi- properties, PPAR␥ ligands such as the thiazolidinediones
ronmental endocrine disruptors for receptor-mediated acti- (TZDs) are used to treat type 2 diabetes. TZDs reverse insulin
vation. We employed a similar ligand screen with GAL4 resistance in the whole body by sensitizing the muscle and
DBD-NR LBD constructs in mammalian cell culture (50). liver tissue to insulin (52). Unfortunately, an undesirable
Surprisingly, organotins such as TBT or triphenyltin act as consequence of this increase in whole-body insulin sensitiv-
potent nanomolar activators of both RXRs and PPAR␥ with ity is an increase in fat mass through the promotion of tri-
equilibrium binding constants (Kd) from 12–20 nm (50). glyceride storage in adipocytes. Activation of thrifty genes
Ligand-binding studies and the pattern of ligand-dependent such as PPAR␥ that divert metabolic energy stores toward fat
recruitment of coactivators followed those observed with under conditions of nutritional stress may have provided an
FIG. 1. Schematic depiction of the known and potential pathways through which TBT might act to modulate adipocyte differentiation and
obesity. TBT at low nanomolar doses can activate RXR and PPAR␥ to directly modulate the activity of genes involved at multiple stages of
adipocyte differentiation. These include early mitogenic genes such as c-jun, transcription factors responsible for clonal expansion and
differentiation such as C/EBP and sterol regulatory element-binding protein 1 (Srebp-1c), as well as direct targets of PPAR␥ signaling such
as adipocyte P2 (aP2), fatty acid synthase, and fatty acid transport protein. The lower left illustrates that TBT at high doses can inhibit aromatase
enzyme activity directly, leading to decreased estradiol levels and down-regulation of estrogen receptor (ER) target genes. However, at low doses,
aromatase transcription can be either up- or down-regulated by organotins in a tissue-specific manner depending on promoter usage. TBT at
moderate to high doses inhibits the activity of 11-HSD2, leading to decreased inactivation of cortisol, thereby increasing local glucocorticoid
levels that could target late stages in adipocyte differentiation. Both 11-HSD1 and -2 are themselves also potential targets of RXR-heterodimer-
mediated transcriptional regulation. E2, Estradiol; GR, glucocorticoid receptor; T, testosterone.
Grün and Blumberg • Are Environmental Chemicals Making Us Fat? Endocrinology, June 2006, 147(6) (Supplement):S50 –S55 S53
factor-responsive transcription factors c-myc, c-fos, and c- coactivator interactions, and could lead to the development
jun, followed by transient expression/switch in C/EBP fac- of a new therapeutic class of insulin sensitizers.
tors from C/EBP/␦ to C/EBP␣. Subsequent induction of The combinatorial role of RXRs as heterodimeric partner
PPAR␥ promotes the expression of terminal adipocyte- to many other nuclear receptors widens the possibility of
specific genes such as aP2. Hence, effective adipocyte for- organotins to perturb lipogenic signaling. Figure 1 summa-
mation in vitro requires the adipogenic hormone cocktail rizes the central role played by RXR-heterodimer signaling
MDI (isobutyl methylxanthine, dexamethasone, and insulin) in adipogenesis and also highlights potential points of in-
to initiate the program and a PPAR␥ agonist for terminal tersection with the sex steroid and glucocorticoid axes. Or-
differentiation. ganotin activation of permissive RXR heterodimer combina-
Conclusions technical and social advancement outstripped evolution? J Intern Med 254:
114 –125
The roles of environmental chemicals in the etiology of 13. Lazar MA 2005 How obesity causes diabetes: not a tall tale. Science 307:373–375
complex diseases such as obesity, type 2 diabetes, and car- 14. Auwerx J 1999 PPAR␥, the ultimate thrifty gene. Diabetologia 42:1033–1049
15. Baillie-Hamilton PF 2002 Chemical toxins: a hypothesis to explain the global
diovascular disease are currently poorly understood. The obesity epidemic. J Altern Complement Med 8:185–192
link that has been forged between organotins and adipocyte 16. Heindel JJ 2003 Endocrine disruptors and the obesity epidemic. Toxicol Sci
differentiation opens an important new area of research into 76:247–249
17. Nilsson R 2000 Endocrine modulators in the food chain and environment.
environmental influences on human health with respect to Toxicol Pathol 28:420 – 431
obesity and related metabolic disorders such as type 2 dia- 18. Toschke AM, Koletzko B, Slikker Jr W, Hermann M, von Kries R 2002
Childhood obesity is associated with maternal smoking in pregnancy. Eur
betes and cardiovascular disease. Mean measured levels of
44. Philbert MA, Billingsley ML, Reuhl KR 2000 Mechanisms of injury in the 55. Rangwala SM, Lazar MA 2000 Transcriptional control of adipogenesis. Annu
central nervous system. Toxicol Pathol 28:43–53 Rev Nutr 20:535–559
45. Mu YM, Yanase T, Nishi Y, Waseda N, Oda T, Tanaka A, Takayanagi R, 56. Inadera H, Shimomura A 2005 Environmental chemical tributyltin augments
Nawata H 2000 Insulin sensitizer, troglitazone, directly inhibits aromatase adipocyte differentiation. Toxicol Lett 159:226 –234
activity in human ovarian granulosa cells. Biochem Biophys Res Commun 57. Canan Koch SS, Dardashti LJ, Cesario RM, Croston GE, Boehm MF, Heyman
271:710 –713 RA, Nadzan AM 1999 Synthesis of retinoid X receptor-specific ligands that are
46. Mu YM, Yanase T, Nishi Y, Takayanagi R, Goto K, Nawata H 2001 Combined potent inducers of adipogenesis in 3T3–L1 cells. J Med Chem 42:742–750
treatment with specific ligands for PPAR␥:RXR nuclear receptor system mark- 58. Zhang Y, Mangelsdorf DJ 2002 LuXuRies of lipid homeostasis: the unity of
edly inhibits the expression of cytochrome P450arom in human granulosa nuclear hormone receptors, transcription regulation, and cholesterol sensing.
cancer cells. Mol Cell Endocrinol 181:239 –248 Mol Interv 2:78 – 87
47. Saitoh M, Yanase T, Morinaga H, Tanabe M, Mu YM, Nishi Y, Nomura M, 59. Evans RM, Barish GD, Wang YX 2004 PPARs and the complex journey to
Okabe T, Goto K, Takayanagi R, Nawata H 2001 Tributyltin or triphenyltin obesity. Nat Med 10:355–361
Endocrinology is published monthly by The Endocrine Society (http://www.endo-society.org), the foremost professional society serving the
endocrine community.